Major depressive disorder (MDD) is a debilitating condition that affects more than 246 million people worldwide, yet scientists have struggled to identify consistent brain markers that could improve ...

Major depressive disorder (MDD) is a debilitating condition that affects more than 246 million people worldwide, yet ...

Patients with asthma and major depressive disorder had more negative beliefs about their asthma, worse treatment adherence ...

A new comprehensive analysis has revealed that major depressive disorder alters both the physical architecture and the ...

In older adults with asthma, major depressive disorder was linked to poorer control and quality of life, partly via negative ...

Patients with depressive symptoms and asthma had elevated levels of serum brain-derived neurotrophic factor in association ...

A team of researchers, through a collaborative study, now points to functional connectome uniqueness (an individual-level ...

Chronic stress can damage the gut’s protective lining, triggering inflammation that may worsen depression. New research shows that stress lowers levels of a protein called Reelin, which plays a key ...

No statistically significant change in MADRS total score was observed with solriamfetol vs placebo in the overall study population. Topline results were announced from a phase 3 trial evaluating ...

Intra-Cellular Therapies’ surging antipsychotic Caplyta has scored again with remarkable trial results, fueling its bid for a third and potentially most lucrative indication—major depressive disorder ...